Meeting
2017 ASCO Annual Meeting
A phase I trial of mifepristone (M), carboplatin (C), and gemcitabine (G) in advanced breast and ovarian cancer.
Authors
Erica Michelle Stringer
University of Alabama at Birmingham, Birmingham, AL
Erica Michelle Stringer , Poornima Saha , April Swoboda , Masha Kocherginsky , Gabrielle Baker , Simona Olberkyte , Nana Owusu , Brittany Dyer , Lauren Olalde , Elizabeth Olszewski , Olwen Mary Hahn , Philip C. Hoffman , Brooke Elizabeth Phillips , Grace K. Suh , Suzanne D. Conzen , Gini F. Fleming , Rita Nanda
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Other Breast Cancer Subtypes
Clinical Trial Registration Number
NCT02046421
Citation
J Clin Oncol 35, 2017 (suppl; abstr 1083)
DOI
10.1200/JCO.2017.35.15_suppl.1083
Abstract #
1083
Poster Bd #
75
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
A phase I/II study of nanoliposomal irinotecan and carboplatin in patients with advanced or metastatic, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma characterized by tissue and liquid next-generation sequencing.
First Author: Nai-Jung Chiang
Poster
2020 ASCO Virtual Scientific Program
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors.
First Author: Jasmine Huynh
Poster
2019 ASCO Annual Meeting
A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
First Author: Nancy Chan
Poster
2018 ASCO Annual Meeting
Phase I trial of lurbinectedin (PM1183) in Japanese patients with advanced tumors: Results of the dose escalation part.
First Author: Shunji Takahashi